
High street pharmacist Boots is set to become the first to provide medical cannabis to patients in the UK.
The private pharmacy will reportedly be able to offer private prescriptions of cannabis for certain medical conditions, LBC reports, which could potentially mean that hundreds of thousands of patients could get access.
Several countries around the world allow for regulated use of medicinal cannabis, including Australia, Canada, and the US, though the precise rules around the production, sale, and consumption of the drug vary by country.
The law can also vary by region, with some US states allowing medical cannabis while others don't, for example.
Advert
Recreational cannabis is illegal in the UK, being a class B drug, the second most severe after class A.
In the UK, class B drugs carry a maximum sentence of five years in prison for possession, and up to 14 years in prison for production or supplying.
Now, Boots has said that using its SureLeaf service online, patients can legally use medical cannabis, though there are some rules in place around how it can be used.

Firstly, patients have to be over the age of 25 in order to be able to use this service with Boots.
The drug will be available with Boots for people who have conditions such as chronic low back and neck pain, generalised anxiety, insomnia, or endometriosis.
In order to qualify, patients must also have tried conventional treatments before requesting medical cannabis.
This will be done by video consultations with patients, with clinicians screening patients for any signs of psychosis or other health conditions which would bar them from the medication.
If they a patient is permitted the prescription this would then be available either as a cannabis flower, or an oil over a 28-day period.
During that time clinicians at Boots will work with patients to check in on them and monitor their dose and how the treatment is working for them, with the lowest dose costing just under £40.
Boots' website says: "When conventional treatments haven’t provided enough relief, SureLeaf offers a legal, trusted and personalised path forwards.

"We provide pharmaceutical-grade medical cannabis to help manage chronic symptoms, with every treatment plan guided by our specialist clinicians to ensure safe, personally tailored care."
According to the NHS around 26 percent of adults report chronic pain, and around five million people in the UK report having insomnia.
Jamie Kerruish is the Chief Healthcare Officer at Boots, and said in a statement to LBC: “At Boots, we’re committed to making healthcare more accessible and helping people find the right support for their individual needs.
"Millions of people live with ongoing pain, and for some, conventional treatments do not provide adequate symptom relief.
"This can have a significant impact on everyday life, from working and sleeping well to spending time with family and doing the things they enjoy.
"Medical cannabis is a specialist area of healthcare and, through SureLeaf, we’re giving eligible patients another treatment option to consider, supported by clinical expertise and robust ongoing care.”



